Bristol-Myers Squibb (BMY) P/B (1999 - 2026)
Bristol-Myers Squibb (BMY) P/B from Nov 1, 1999 to Jul 21, 2026. The TTM Bristol-Myers Squibb (BMY) P/B is 6.19. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/B
Annual P/B change of Bristol-Myers Squibb (BMY)
| Year | P/B | Change |
|---|---|---|
| 2026 | 6.19 | +4.07% |
| 2025 | 5.94 | -15.34% |
| 2024 | 7.02 | +92.93% |
| 2023 | 3.64 | -22.52% |
| 2022 | 4.70 | +22.04% |
| 2021 | 3.85 | +3.98% |
| 2020 | 3.70 | +82.32% |
| 2019 | 2.03 | -66.42% |
| 2018 | 6.05 | -11.01% |
| 2017 | 6.79 | +8.63% |
| 2016 | 6.25 | -22.24% |
| 2015 | 8.04 | +22.05% |
| 2014 | 6.59 | +14.15% |
| 2013 | 5.77 | +44.85% |
| 2012 | 3.99 | +10.38% |
| 2011 | 3.61 | +25.15% |
| 2010 | 2.89 | -16.78% |
| 2009 | 3.47 | -10.44% |
| 2008 | 3.87 | +43.73% |
| 2007 | 2.69 | +0.76% |
| 2006 | 2.67 | +14.53% |
| 2005 | 2.33 | -10.30% |
| 2004 | 2.60 | -10.42% |
| 2003 | 2.90 | +23.54% |
| 2002 | 2.35 | -54.61% |
| 2001 | 5.18 | -31.03% |
| 2000 | 7.51 | +15.19% |
| 1999 | 6.52 | N/A |
Comparison Bristol-Myers Squibb (BMY) P/B with competitors
Bristol-Myers Squibb (BMY) P/B is 6.19.
| Ticker | Name | P/B | Upside |
|---|---|---|---|
| AMRN | Amarin Corp | 0.68 | -88.94% |
| GRFS | Grifols SA | 0.79 | -87.23% |
| SNY | Sanofi | 1.27 | -79.47% |
| BIIB | Biogen Inc | 1.52 | -75.45% |
| PFE | Pfizer Inc | 1.55 | -74.98% |
| OGN | Organon & Company | 3.93 | -36.55% |
| MIRA | Mira Pharmaceuticals Inc | 4.09 | -33.88% |
| GSK | GSK Plc | 4.37 | -29.34% |
| AZN | Astrazeneca plc | 6.20 | +0.21% |
| MRK | Merck & Co Inc | 6.68 | +7.96% |
| GILD | Gilead Sciences Inc | 6.94 | +12.17% |
| NVO | Novo Nordisk | 7.07 | +14.27% |
| NVS | Novartis AG | 7.60 | +22.83% |
| JNJ | Johnson & Johnson | 7.64 | +23.48% |
| NSRX | Nasus Pharma Ltd | 12.90 | +108.49% |
| MDCX | MDCorp | 15.34 | +147.93% |
| AMGN | AMGEN Inc | 21.17 | +242.16% |
| SCLX | Scilex Holding Company | 28.85 | +366.28% |
| LLY | Lilly(Eli) & Company | 32.94 | +432.39% |
| ABBV | Abbvie Inc | 50.46 | +715.55% |